PIEZO1 and neoplasm: (D) MC38 OVA tumor cells were implanted subcutaneously in WT and Piezo1-/- mice (n=10) and at day 20, the CD45.1+ donor CFSE+OTII CD4+T cells were transferred into WT and Piezo1-/- tumor-bearing mice for 10 days.